In vivo studies of cerebral angiogenesis and oxygenation
脑血管生成和氧合的体内研究
基本信息
- 批准号:7488554
- 负责人:
- 金额:$ 18.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-09-20 至 2010-05-31
- 项目状态:已结题
- 来源:
- 关键词:AcclimatizationAdenovirus VectorAdenovirusesAdultAltitudeAnemiaAnimalsBiologicalBlood VesselsBlood VolumeBlood capillariesBrainBrain InjuriesCerebral EdemaCerebrumChronicClinicalConditionDialysis procedureDisease regressionElectron Spin Resonance SpectroscopyExposure toFluorescein-5-isothiocyanateGene ExpressionGenesGrowthHIF1A geneHemoglobinHypoxiaImageInvasiveIschemiaLinkLongitudinal StudiesLung diseasesMagnetic Resonance ImagingMeasuresMethodsModalityMolecularMonitorNMR SpectroscopyNear-Infrared SpectroscopyOutcomeOxygenOxygen measurement, partial pressure, arterialOxygen saturation measurementOxyhemoglobinPECAM1 geneParkinson DiseasePhysical DialysisProcessProductionProteinsProtocols documentationRangeRecoverySudden infant death syndromeTestingTimeTissuesUp-RegulationVascular Endothelial Growth FactorsWeekWorkangiogenesisbrain tissuecapillarydaydensityhypoxia inducible factor 1improvedin vivoindexinginfrared spectroscopymultidisciplinaryprogramsresponserestorationtime usetissue oxygenationtool
项目摘要
DESCRIPTION (provided by applicant): There are many clinical conditions where the brain may be damaged from chronic hypoxia including ischemia, pulmonary disorders, SIDS, anemia, dialysis, high altitude cerebral edema and Parkinson's disease. If chronic hypoxia does cause brain damage, it follows that the adaptation of the brain to chronic hypoxia is incomplete, and may be improved through induction of angiogenesis. Recent work indicates that the brain is capable of adaptation to low oxygen through angiogenesis. There is strong evidence that HIF-1alpha is a major regulatory factor in this process. We have assembled a multidisciplinary program using our unique combination of tools (including molecular biological methods, near-infrared spectroscopy, NMR and electron paramagnetic resonance) to determine the impact of tissue hypoxia on HIF-1alpha in normal and ischemic brain, and to determine the temporal link between the upregulation of HIF-1alpha and changes in brain tissue oxygenation and angiogenesis. Cerebral oxygenation is defined as the mean cerebral hemoglobin saturation (SmcO2) measured using near-infrared (NIR) spectroscopy, and the tissue pO2 (PtO2) measured using electron paramagnetic resonance (EPR) spectroscopy. In Aim 1 we study the link between HIF-1alpha stabilization and PtO2. Aim 2 will study the response of the brain to chronic hypoxia, and to the re-supply of oxygen. This includes the time-course of increased and decreased HIF-1alpha, the time-course of angiogenesis and angioregression (measured using morphometrics and cerebral blood volume where CBV is measured with quantitative NIR spectroscopy and with steady-state contrast enhanced NMR imaging), and the changes in oxygenation. Aim 3 following a similar protocol, will study chronic low flow ischemia. We will determine if HIF-1alpha is upregulated, the time-course of angiogenesis, and whether cerebral oxygenation shows complete recovery. Aim 4 will determine if the Genzyme adenovirus, containing a non-oxygen responsive HIF-1alpha construct, will result in increased HIF-1alpha protein and increased vascular density. These studies will improve our understanding of the link between angiogenesis, HIF-1alpha upregulation and oxygenation in brain, and will lay the groundwork for manipulation of angiogenesis to improve outcome from chronic hypoxia or ischemia.
描述(由申请人提供):在许多临床状况下,大脑可能因缺血,肺部疾病,SIDS,贫血,透析,高海拔大脑水肿和帕金森氏病而受到慢性缺氧的损害。如果慢性缺氧确实会导致脑损伤,则得出的是,大脑对慢性缺氧的适应性不完整,并且可以通过诱导血管生成来改善。最近的工作表明,大脑能够通过血管生成适应低氧。有强有力的证据表明,HIF-1Alpha是此过程中的主要调节因素。我们已经使用我们独特的工具组合(包括分子生物学方法,近红外光谱,NMR和电子顺磁性共振)组装了一个多学科计划,以确定组织缺氧对正常和缺血性脑部HIF-1Alpha的影响,并确定hante-ox的临时脑部的临时链接和脑部的变化和脑部的变化。脑氧合定义为使用近红外(NIR)光谱法测量的平均脑血红蛋白饱和度(SMCO2),使用电子顺磁共振(EPR)光谱法测量的组织PO2(PTO2)。在AIM 1中,我们研究了HIF-1Alpha稳定和PTO2之间的联系。 AIM 2将研究大脑对慢性缺氧的反应,以及对氧气的重新供应。这包括增加和减少HIF-1Alpha的时间顺序,血管生成和血管造成的时间顺序(使用形态图和脑血体积测量,其中用定量NIR光谱和稳态对比度对NMR Imaging进行CBV测量),以及氧气的变化。遵循类似方案的目标3将研究慢性低流量缺血。我们将确定HIF-1Alpha是否上调,血管生成的时间顺序以及脑氧合是否显示完全恢复。 AIM 4将确定含有非氧气响应HIF-1Alpha构建体的腺病毒是否会导致HIF-1Alpha蛋白增加并增加血管密度。这些研究将提高我们对脑血管生成,HIF-1Alpha上调和氧合之间联系的理解,并将为操纵血管生成的基础,以改善慢性低氧或缺血的结果。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Blood-oxygen-level-dependent magnetic resonance signal and cerebral oxygenation responses to brain activation are enhanced by concurrent transient hypertension in rats.
大鼠中并发短暂性高血压可增强血氧水平依赖性磁共振信号和对大脑激活的脑氧合反应。
- DOI:10.1038/sj.jcbfm.9600436
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Qiao,Min;Rushforth,Dave;Wang,Rong;Shaw,RAnthony;Tomanek,Boguslaw;Dunn,JeffF;Tuor,UrsulaI
- 通讯作者:Tuor,UrsulaI
Monitoring angiogenesis noninvasively with near-infrared spectroscopy.
使用近红外光谱无创监测血管生成。
- DOI:10.1117/1.3000431
- 发表时间:2008
- 期刊:
- 影响因子:3.5
- 作者:Dunn,JeffreyF;Zhang,Qiong;Wu,Ying;Srinivasan,Sathyanarayanan;Smith,MichaelR;Shaw,RAnthony
- 通讯作者:Shaw,RAnthony
Measuring oxygenation in vivo with MRS/MRI--from gas exchange to the cell.
使用 MRS/MRI 测量体内氧合——从气体交换到细胞。
- DOI:10.1089/ars.2007.1625
- 发表时间:2007
- 期刊:
- 影响因子:6.6
- 作者:Dunn,JF
- 通讯作者:Dunn,JF
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jeffrey Frank Dunn其他文献
Jeffrey Frank Dunn的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jeffrey Frank Dunn', 18)}}的其他基金
2022 In Vivo Magnetic Resonance Gordon Research Conference and Gordon Research Seminar
2022体内磁共振戈登研究会议暨戈登研究研讨会
- 批准号:
10611143 - 财政年份:2022
- 资助金额:
$ 18.94万 - 项目类别:
Development and validation of a multimodal MRI/near-infrared spectroscopysystem to study brain oxidative metabolism in mouse models of neurologicaldisease
开发和验证多模态 MRI/近红外光谱系统,用于研究神经系统疾病小鼠模型的脑氧化代谢
- 批准号:
9326993 - 财政年份:2016
- 资助金额:
$ 18.94万 - 项目类别:
In vivo studies of cerebral angiogenesis and oxygenation
脑血管生成和氧合的体内研究
- 批准号:
6723490 - 财政年份:2004
- 资助金额:
$ 18.94万 - 项目类别:
In vivo studies of cerebral angiogenesis and oxygenation
脑血管生成和氧合的体内研究
- 批准号:
7271985 - 财政年份:2004
- 资助金额:
$ 18.94万 - 项目类别:
In vivo studies of cerebral angiogenesis and oxygenation
脑血管生成和氧合的体内研究
- 批准号:
6949665 - 财政年份:2004
- 资助金额:
$ 18.94万 - 项目类别:
Near infrared/MR system for imaging brain oxygenation
用于脑氧合成像的近红外/MR系统
- 批准号:
6326330 - 财政年份:2001
- 资助金额:
$ 18.94万 - 项目类别:
Near infrared/MR system for imaging brain oxygenation
用于脑氧合成像的近红外/MR系统
- 批准号:
6540065 - 财政年份:2001
- 资助金额:
$ 18.94万 - 项目类别:
Near infrared/MR system for imaging brain oxygenation
用于脑氧合成像的近红外/MR系统
- 批准号:
6615724 - 财政年份:2001
- 资助金额:
$ 18.94万 - 项目类别:
BLOOD OXYGEN LEVEL DEPENDENT (BOLD) MR IMAGING & BRAIN OXYGEN TENSION
血氧水平相关(粗体)MR 成像
- 批准号:
6353202 - 财政年份:2000
- 资助金额:
$ 18.94万 - 项目类别:
相似国自然基金
基于sIgA的V(D)J结构多样性探索腺病毒载体鼻喷新冠奥密克戎疫苗诱导的呼吸道粘膜免疫原性特征
- 批准号:82302607
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
新型腺病毒载体Ad49L介导的高水平干扰素α抑制疫苗体液免疫的机制
- 批准号:82302001
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
新型腺病毒载体疫苗长效免疫机制
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
新型腺病毒载体疫苗长效免疫机制
- 批准号:82271868
- 批准年份:2022
- 资助金额:53.00 万元
- 项目类别:面上项目
基于肠道腺病毒载体平台COVID-19粘膜疫苗的设计与筛选
- 批准号:82161138001
- 批准年份:2021
- 资助金额:150 万元
- 项目类别:国际(地区)合作与交流项目
相似海外基金
Advancing Systematic Delivery of Oncolytic Adenovirus for Pancreatic Cancer
推进溶瘤腺病毒治疗胰腺癌的系统递送
- 批准号:
10734709 - 财政年份:2023
- 资助金额:
$ 18.94万 - 项目类别:
A novel therapeutic approach for Alzheimer Disease (AD)
阿尔茨海默病(AD)的新治疗方法
- 批准号:
10740016 - 财政年份:2023
- 资助金额:
$ 18.94万 - 项目类别:
Pulmonary endothelium targeted adenoviral gene therapy for the correction of mucopolysaccharidosis type I
肺内皮靶向腺病毒基因治疗纠正 I 型粘多糖贮积症
- 批准号:
10678053 - 财政年份:2023
- 资助金额:
$ 18.94万 - 项目类别:
Inducible HMGB1 antagonist for viral-induced acute lung injury.
诱导型 HMGB1 拮抗剂,用于治疗病毒引起的急性肺损伤。
- 批准号:
10591804 - 财政年份:2023
- 资助金额:
$ 18.94万 - 项目类别: